Back to all papers

Clinical utility of foundation models in musculoskeletal MRI for biomarker fidelity and predictive outcomes.

March 24, 2026pubmed logopapers

Authors

Hoyer G,Tong MW,Bhattacharjee R,Pedoia V,Majumdar S

Affiliations (8)

  • Center for Intelligent Imaging, Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA. [email protected].
  • Department of Bioengineering, University of California, Berkeley, CA, USA. [email protected].
  • Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA. [email protected].
  • Center for Intelligent Imaging, Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA.
  • Department of Bioengineering, University of California, Berkeley, CA, USA.
  • Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA.
  • Department of Medical Sciences and Technology, Indian Institute of Technology Madras, Chennai, India.
  • Bay Area Institute of Computation, Altos Labs, Redwood City, CA, USA.

Abstract

Precision medicine in musculoskeletal imaging requires scalable measurement infrastructure. We developed a modular system that converts routine MRI into standardized quantitative biomarkers suitable for clinical decision support. Promptable foundation segmenters (SAM, SAM2, MedSAM) were fine-tuned across heterogeneous musculoskeletal datasets and coupled to automated detection for fully automatic prompting. Fine-tuned segmentations yielded clinically reliable measurements with high concordance to expert annotations across cartilage, bone, and soft tissue biomarkers. Using the same measurements, we demonstrate two applications: (i) a three-stage knee triage cascade that reduces verification workload while maintaining sensitivity, and (ii) 48-month landmark models that forecast knee replacement and incident osteoarthritis with favorable calibration and net benefit across clinically relevant thresholds. Our model-agnostic, open-source architecture enables independent validation and development. This work validates a pathway from automated measurement to clinical decision: reliable biomarkers drive both workload optimization today and patient risk stratification tomorrow, and the developed framework shows how foundation models can be operationalized within precision medicine systems.

Topics

Journal Article

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.